1. Home
  2. REXR vs GRFS Comparison

REXR vs GRFS Comparison

Compare REXR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REXR
  • GRFS
  • Stock Information
  • Founded
  • REXR 2013
  • GRFS 1940
  • Country
  • REXR United States
  • GRFS Spain
  • Employees
  • REXR N/A
  • GRFS N/A
  • Industry
  • REXR Real Estate Investment Trusts
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • REXR Real Estate
  • GRFS Health Care
  • Exchange
  • REXR Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • REXR 8.6B
  • GRFS 7.2B
  • IPO Year
  • REXR 2013
  • GRFS 2006
  • Fundamental
  • Price
  • REXR $42.87
  • GRFS $9.63
  • Analyst Decision
  • REXR Hold
  • GRFS Hold
  • Analyst Count
  • REXR 9
  • GRFS 1
  • Target Price
  • REXR $40.78
  • GRFS $10.30
  • AVG Volume (30 Days)
  • REXR 2.8M
  • GRFS 489.5K
  • Earning Date
  • REXR 10-15-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • REXR 4.02%
  • GRFS 1.47%
  • EPS Growth
  • REXR 11.21
  • GRFS 132.60
  • EPS
  • REXR 1.35
  • GRFS 0.53
  • Revenue
  • REXR $986,532,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • REXR $9.35
  • GRFS $6.00
  • Revenue Next Year
  • REXR $6.25
  • GRFS $6.71
  • P/E Ratio
  • REXR $31.79
  • GRFS $24.37
  • Revenue Growth
  • REXR 13.72
  • GRFS 9.32
  • 52 Week Low
  • REXR $29.68
  • GRFS $6.19
  • 52 Week High
  • REXR $52.37
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • REXR 65.41
  • GRFS 40.71
  • Support Level
  • REXR $42.50
  • GRFS $9.79
  • Resistance Level
  • REXR $43.79
  • GRFS $10.14
  • Average True Range (ATR)
  • REXR 0.83
  • GRFS 0.18
  • MACD
  • REXR 0.09
  • GRFS -0.03
  • Stochastic Oscillator
  • REXR 75.97
  • GRFS 9.23

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: